Company Filing History:
Years Active: 2013-2023
Title: Claudio Pollo: Innovator in Neurological Devices
Introduction
Claudio Pollo is a distinguished inventor based in Lausanne, Switzerland. He has made significant contributions to the field of neurological devices, holding a total of 4 patents. His work focuses on developing innovative solutions for interacting with neurological tissue, which has the potential to advance medical treatments for neurological disorders.
Latest Patents
One of Claudio Pollo's latest patents is a device for interacting with neurological tissue and methods of making and using the same. This invention describes microelectrode array devices and methods of fabrication, assembly, and use to provide highly localized neural recording and/or neural stimulation to a neurological target. The device includes multiple microelectrode elements arranged in protruding shafts, which are enclosed within an elongated probe shaft and can be expanded from their enclosure. The microelectrode elements and elongated probe shafts are dimensioned to target small volumes of neurons located within the nervous system, particularly in the deep brain region. This probe can quickly identify the location of a neurological target and remain implanted for long-term monitoring and/or stimulation.
Career Highlights
Claudio Pollo has worked at prestigious institutions such as École Polytechnique Fédérale de Lausanne and Université de Lausanne. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in neurological technologies.
Collaborations
Throughout his career, Claudio has collaborated with notable colleagues, including André Mercanzini and Philippe Renaud. These partnerships have enriched his work and fostered innovation in the development of neurological devices.
Conclusion
Claudio Pollo's contributions to the field of neurological devices exemplify the impact of innovative thinking in medical technology. His patents and collaborations highlight his commitment to advancing the understanding and treatment of neurological conditions.